Strongyloidiasis: Epidemiology, clinical manifestations and new methods for diagnosis and treatment

[1]  F. Kinjo,et al.  [Clinical study of eradicated and resistant patients to treatment with ivermectin for strongyloidiasis]. , 1992, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

[2]  H. Sakiyama,et al.  CURRENT STATUS OF STRONGYLOIDES INFECTION IN OKINAWA, JAPAN , 1992 .

[3]  F. Kinjo,et al.  [Long term eradication rate of mebendazole therapy for strongyloidiasis]. , 1992, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

[4]  A. Saito,et al.  CLINICAL STUDY OF MEBENDAZOLE THERAPY FOR STRONGYLOIDIASIS , 1991 .

[5]  K Koga,et al.  A modified agar plate method for detection of Strongyloides stercoralis. , 1991, The American journal of tropical medicine and hygiene.

[6]  F. Kinjo,et al.  [Clinical study on ivermectin against Strongyloides stercoralis]. , 1991, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

[7]  F. Kinjo,et al.  [Treatment of strongyloidiasis with mebendazole--long-term eradication and new trials]. , 1991, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

[8]  F. Kinjo,et al.  [New trial with thiabendazole for treatment of human strongyloidiasis]. , 1991, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

[9]  M. Takara,et al.  Application of enzyme-linked immunosorbent assay for mass examination of strongyloidiasis in Okinawa, Japan. , 1990, International journal for parasitology.

[10]  F. Kinjo,et al.  [Treatment of strongyloidiasis with mebendazole and its combination with thiabendazole]. , 1990, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

[11]  B. Greene,et al.  Safety of and compliance with community-based ivermectin therapy , 1990, The Lancet.

[12]  佐藤 良也,et al.  Clinical Studies on Human Strongyloidiasis in Okinawa,Japan , 1990 .

[13]  M. Iwanaga,et al.  Efficacy of agar-plate culture in detection of Strongyloides stercoralis infection. , 1990, The Journal of parasitology.

[14]  J. Remmé,et al.  Lack of adverse reactions in ivermectin treatment of onchocerciasis , 1990, The Lancet.

[15]  F. Inoue,et al.  Immunoblot analysis of antibodies in human strongyloidiasis. , 1990, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[16]  E. Ette,et al.  Ivermectin: A Long-Acting Microfilaricidal Agent , 1990, DICP : the annals of pharmacotherapy.

[17]  Yoshiya Sato,et al.  Clinical studies on human strongyloidiasis in Okinawa, Japan. , 1990 .

[18]  J. H. Cross.  Strongyloidiasis: A major roundworm infection of man , 1990 .

[19]  H. Fukuhara,et al.  [A case report of meningitis and sepsis due to Enterococcus faecium complicated with strongyloidiasis]. , 1989, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

[20]  W. Wilson,et al.  SIDE-EFFECTS OF IVERMECTIN IN TREATMENT OF ONCHOCERCIASIS , 1989, The Lancet.

[21]  D. Freedman,et al.  The efficacy of ivermectin in the chemotherapy of gastrointestinal helminthiasis in humans. , 1989, The Journal of infectious diseases.

[22]  C. O'Hara,et al.  Pathology And Pathophysiology of AIDS And Hiv-related Diseases , 1989 .

[23]  M. Iwanaga,et al.  A NEW METHOD TO DETECT STRONGYLOIDES STERCORALIS FROM HUMAN STOOL , 1988 .

[24]  B. Rodriguez-Iturbe,et al.  Adult respiratory distress secondary to strongyloidiasis. , 1987, Chest.

[25]  G. Wormser,et al.  Strongyloides stercoralis hyperinfection in a patient with the acquired immune deficiency syndrome. , 1987, The American journal of medicine.

[26]  K. Yamaguchi,et al.  Monoclonal integration of HTLV‐I proviral DNA in patients with strongyloidiasis , 1987, International journal of cancer.

[27]  F. Derouin,et al.  AIDS AND STRONGYLOIDIASIS IN AFRICA , 1987, The Lancet.

[28]  R. Genta,et al.  Diagnostic implications of parasite-specific immune responses in immunocompromised patients with strongyloidiasis , 1986, Journal of clinical microbiology.

[29]  J. Young,et al.  Strongyloides stercoralis hyperinfestation syndrome with Escherichia coli meningitis: report of two cases. , 1986, Journal of clinical pathology.

[30]  A. Verghese,et al.  Pulmonary strongyloidiasis. Diagnosis by sputum gram stain. , 1985, The American journal of medicine.

[31]  F. Derouin,et al.  DOUBLE-BLIND STUDY OF IVERMECTIN AND DIETHYLCARBAMAZINE IN AFRICAN ONCHOCERCIASIS PATIENTS WITH OCULAR INVOLVEMENT , 1985, The Lancet.

[32]  H. Rocha,et al.  Immunological features in different clinical forms of strongyloidiasis. , 1983, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[33]  D. E. Justus,et al.  Strongyloidiasis in immunosuppressed patients. , 1981, American journal of clinical pathology.

[34]  D. Louria,et al.  Syndrome of hyperinfection with Strongyloides stercoralis. , 1981, Reviews of infectious diseases.

[35]  M. Pohlman,et al.  CLINICAL TRIALS WITH THIABENDAZOLE AGAINST INTESTINAL NEMATODES INFECTING HUMANS. , 1965, American Journal of Tropical Medicine and Hygiene.

[36]  F. W. Nugent,et al.  Strongyloides stercoralis. , 1961, The Lahey Clinic bulletin.